Pharm
Lithium Toxicity
search
Lithium Toxicity
, Lithium Poisoning, Lithium Intoxication
See Also
Lithium
Epidemiology
Incidence
of Lithium Intoxication: 7000 cases/year U.S.
Most patients on chronic
Lithium
will experience at least one episode of toxicity
Mortality
Current: <1%
Historical: 9 to 25%
Mechanism
Lithium
has a narrow therapeutic range
Lithium
concentrates most in CNS and renal tissue
Pharmacokinetics
See
Lithium
Risk Factors
Toxicity
Renal dysfunction (Low
Glomerular Filtration Rate
)
Sodium
Retention states (associated with greater
Lithium
reabsorption)
Volume depletion (
Vomiting
or
Diarrhea
,
Diuretic
s)
Acute Heart Failure
Cirrhosis
Medications
Thiazide Diuretic
s (e.g.
Hydrochlorothiazide
,
Chlorthalidone
)
Spironolactone
ACE Inhibitor
s
NSAID
S
Calcium Channel Blocker
s
Socioeconomic Factors
Poor health care access
Poor living conditions
Findings
Gene
ral Based on Timing of Presentation
Acute Lithium Toxicity
Early Findings: Gastrointestinal symptoms
Late Findings: Neurologic symptoms
Acute on Chronic Toxicity
Early Findings: Gastrointestinal symptoms (more severe than in acute toxicity alone)
Late Findings: Neurologic symptoms (may appear sooner than in acute toxicity alone)
Chronic Toxicity
Neurologic findings
No delay in neurologic findings as
Lithium
distribution in the CNS has already occurred
Findings
Gastrointestinal
Nausea
or
Vomiting
Lithium
may cause
Nausea
as an adverse effect, but
Vomiting
is a red flag for toxicity
Gastrointestinal losses and
Dehydration
(with decreased GFR) may worsen toxicity
Diarrhea
Abdominal Pain
Findings
Neurologic (late sign in acute toxicity, common in chronic toxicity)
Listless or sluggish
Ataxia
Confusion
Agitation
Tremor
s or
Myoclonic Jerk
s
Lithium
Tremor
May be seen in patients on chronic
Lithium
WITHOUT toxicity
Symmetric, upper extremity fine motor
Tremor
Lithium Toxicity
Tremor
Course, more severe
Tremor
that may affect all extremities
Seizure
s and encephalopathy (severe cases)
See below for Syndrome of Irreversible
Lithium
Effectuated Neurotoxicity (SILENT)
Labs
Gene
ral
Complete Blood Count
(CBC)
White Blood Cell Count
is commonly increased with Lithium Toxicity
Serum chemistry (chem8)
Nephrotoxicity (especially associated with chronic Lithium Toxicity)
Increased
Serum Creatinine
,
Blood Urea Nitrogen
Nephrogenic Diabetes Insipidus
(typically with chronic Lithium Toxicity)
Hyponatremia
Lithium
is not typically associated with acid base disorders
See
Unknown Ingestion
Consider coingestion (e.g.
Toxic Alcohol
s)
Urine Pregnancy Test
Urinalysis
Very low
Urine Specific Gravity
in
Nephrogenic Diabetes Insipidus
Thyroid Stimulating Hormone
(TSH)
Hypothyroidism
or
Hyperthyroidism
Unknown Ingestion
and
Altered Level of Consciousness
testing
Venous Blood Gas
Acetaminophen
Level
Salicylate
Level
Urine Drug Screen
Serum Glucose
Labs
Lithium
Level
Precautions
Peak levels may not be reached for >12 hours after
Overdose
of sustained release
Lithium
For a given level, symptoms may be more mild in acute toxicity than in chronic toxicity
Obtain levels every 4 hours to trend absorption and distribution until the level peaks
Lithium
levels may be initially needed every 4 to 6 hours for >24 hours
Therapeutic Level: 0.8 to 1.2 mEq/L
Mild Toxicity: 1.5 to 2.5 mEq/L (Hansen and Amdisen Grade 1)
Tremor
Slurred Speech
Listlessness
Ataxia
Nausea
or
Vomiting
Moderate Toxicity: 2.5 to 3.5 mEq/L (Hansen and Amdisen Grade 2)
Stupor
Rigidity and hypertonia
Hypotension
Severe Toxicity: >3.5 mEq/L (Hansen and Amdisen Grade 3)
Encephalopathy or coma
Seizure
s
Myoclonus
Diagnostics
Electrocardiogram
(EKG changes are uncommon)
QTc Prolongation
(increased risk with higher
Lithium
levels)
T Wave Flattening
Sinus Bradycardia
Heart Block
Ventricular tachyarrhythmias
Differential Diagnosis
See
Altered Level of Consciousness
See
Unknown Ingestion
Serotonin Syndrome
Neuroleptic Malignant Syndrome
Alcohol Withdrawal
Benzodiazepine Withdrawal
Closed Head Injury
Cerebrovascular Accident
Thyroid
Disease (e.g.
Thyrotoxicosis
,
Myxedema Coma
)
Hypoglycemia
Management
Gene
ral
See
ABC Management
Gastric Decontamination
(acute toxicity only)
AVOID
Activated Charcoal
(no benefit)
Lithium
is not absorbed by
Activated Charcoal
Whole Bowel Irrigation
Consider in awake asymptomatic patients
Extended release acute ingestions (e.g.
Lithium
SR) within first 2-4 hours
Immediate release acute large ingestions within first hour
Give 500 to 2000 ml
Polyethylene Glycol
via
Nasogastric Tube
until rectal output clear
Fluid
Resuscitation
First-line management of Lithium Toxicity
Isotonic crystalloid (NS or LR)
Administer initial 2 Liter bolus of crystalloid, followed by 200 ml/hour (2x maintenance)
Rate of replacement should be decreased if
Hyponatremia
(prevent
Central Pontine Myelinolysis
)
Avoid
Diuretic
s (may worsen toxicity and fluid status)
If
Diuretic
s are needed, monitor closely volume status and intake and output (e.g. ICU)
Altered Mental Status
See
Altered Level of Consciousness
See
Unknown Ingestion
Bedside
Serum Glucose
(and treat
Hypoglycemia
)
Consider
Naloxone
Consider
Thiamine
Seizure
s
See
Status Epilepticus
Benzodiazepine
s
Disposition
Evaluate for
Suicidality
in possible intentional
Overdose
Admit Lithium Toxicity to medical ward (severe toxicity to ICU)
May discharge when patient is asymptomatic and serum
Lithium
<1.5 mEq/L
Asymptomatic patient Emergency Department Indications for home discharge
Multiple downward trending
Lithium
levels (including a final
Lithium
level <1.0 mEq/L) AND
Normal
Renal Function
AND
Unremarkable 4 to 6 hour observation
Management
Hemodialysis Indications
Serum
Lithium
Level >5 mEq/L
Serum
Lithium
Level >4 mEq/L AND concurrent
Serum Creatinine
>2.0 mg/dl)
Serum
Lithium
Level >2.5 mEq/L AND
Neurologic symptoms (
Seizure
s, decreased mental status) OR
Conditions in which flud
Resuscitation
is limited (e.g.
Congestive Heart Failure
) OR
Conditions limiting
Lithium
excretion (e.g.
Renal Failure
)
Serum
Lithium
Level >1.5 mEq/L AND
Life threatening complications attributed to Lithium Toxicity
Increasing serum
Lithium
levels despite maximal medical therapy with fluid
Resuscitation
Complications
Chronic Lithium Toxicity
Syndrome of Irreversible
Lithium
Effectuated Neurotoxicity (SILENT)
Higher risk with acute Lithium Toxicity
Persistent neurologic and psychiatric effects despite
Lithium
discontinuation
Effects may include
Extrapyramidal Effect
s,
Dementia
,
Ataxia
, visual changes,
Brainstem
or cerebellar dysfunction
Nephrogenic Diabetes Insipidus
Thyroid
Dysfunction
References
Perrone and Chatterjee (2018) UpToDate, accessed 8/20/2018
Micromedex, accessed 8/20/2018
Mike Avila, MD (2018), email communication, received 8/15/2018
Clark, Pang and Al Jalbout (2025) Crit Dec Emerg Med 39(4): 29-37 [PubMed]
Type your search phrase here